• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微血管密度对胰腺癌根治性切除术后淋巴结转移和生存的影响。

Impact of microvessel density on lymph node metastasis and survival after curative resection of pancreatic cancer.

机构信息

Department of Visceral, Transplantation, Thoracic and Vascular Surgery, University Hospital Leipzig, Liebigstrasse 20, 04103, Leipzig, Germany.

出版信息

Surg Today. 2012 Jan;42(2):169-76. doi: 10.1007/s00595-011-0045-0. Epub 2011 Nov 10.

DOI:10.1007/s00595-011-0045-0
PMID:22068680
Abstract

PURPOSE

The roles of angiogenesis and the most prominent angiogenic vascular endothelial growth factor (VEGF) in diseases of the pancreas remain controversial. We compared microvessel density (MVD) and VEGF status in normal pancreatic, chronic pancreatic, and pancreatic cancer (PC) tissues to establish their prognostic relevance.

METHODS

Eighty samples of PC tissue, 32 samples of normal pancreatic tissue, and 20 samples of chronic pancreatitis (cP) tissue were immunostained with monoclonal anti-CD31 and polyclonal anti-VEGF antibody. The MVD was correlated with clinicopathological features and survival.

RESULTS

Microvessel density was higher in PC than in cP (P < 0.001). Residual tumor status was highly predictive for survival (P < 0.001). After stratification for residual tumor status, we identified lymph node metastasis (LNM) in more than two lymph nodes (P < 0.04) and high MVD (P < 0.03) as risk factors for mortality. Multivariate analysis revealed only a high MVD (P = 0.03, odds ratio 0.441, 95% confidence interval 0.211-0.821) as an independent predictor of poor survival. Vascular endothelial growth factor was found over stromal cells in cP and over ductal adenocarcinoma cells in PC. Vascular endothelial growth factor expression status was not predictive of survival (P < 0.07).

CONCLUSION

This study confirms the role of angiogenesis in PC and identifies MVD as an independent prognostic factor in patients with curatively resected PC.

摘要

目的

血管生成及其最显著的血管内皮生长因子(VEGF)在胰腺疾病中的作用仍存在争议。我们比较了正常胰腺、慢性胰腺炎和胰腺癌(PC)组织中的微血管密度(MVD)和 VEGF 状态,以确定其预后相关性。

方法

免疫组化染色用抗 CD31 单克隆抗体和抗 VEGF 多克隆抗体对 80 例 PC 组织、32 例正常胰腺组织和 20 例慢性胰腺炎(cP)组织进行染色。MVD 与临床病理特征和生存相关。

结果

PC 组织中的 MVD 高于 cP(P<0.001)。残留肿瘤状态对生存有高度预测性(P<0.001)。在按残留肿瘤状态分层后,我们发现淋巴结转移(LNM)超过两个淋巴结(P<0.04)和高 MVD(P<0.03)是死亡率的危险因素。多变量分析显示,只有高 MVD(P=0.03,优势比 0.441,95%置信区间 0.211-0.821)是预后不良的独立预测因素。VEGF 存在于 cP 的间质细胞中,也存在于 PC 的导管腺癌细胞中。VEGF 表达状态与生存无关(P<0.07)。

结论

本研究证实了血管生成在 PC 中的作用,并确定了 MVD 是可切除 PC 患者的独立预后因素。

相似文献

1
Impact of microvessel density on lymph node metastasis and survival after curative resection of pancreatic cancer.微血管密度对胰腺癌根治性切除术后淋巴结转移和生存的影响。
Surg Today. 2012 Jan;42(2):169-76. doi: 10.1007/s00595-011-0045-0. Epub 2011 Nov 10.
2
Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.血管生成和组织蛋白酶表达是根治性切除术后胰腺腺癌的预后因素。
Int J Pancreatol. 2000 Aug;28(1):31-9. doi: 10.1385/IJGC:28:1:31.
3
VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.血管内皮生长因子和Id-1在胰腺腺癌中的预后意义及对血管生成的影响
Eur J Surg Oncol. 2014 Oct;40(10):1331-7. doi: 10.1016/j.ejso.2014.01.004. Epub 2014 Jan 18.
4
High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.血管内皮生长因子的高表达预示着胰腺导管腺癌根治性切除术后的早期复发和不良预后。
Pancreas. 2002 Aug;25(2):122-9. doi: 10.1097/00006676-200208000-00002.
5
Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors.微血管密度低是胰腺内分泌肿瘤中一个不利的组织预后因素。
Gastroenterology. 2003 Oct;125(4):1094-104. doi: 10.1016/s0016-5085(03)01198-3.
6
Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.肿瘤内 α-SMA 增强了 CD34 的预后效力,与肝癌和胰腺癌中小血管完整性的维持有关。
PLoS One. 2013 Aug 5;8(8):e71189. doi: 10.1371/journal.pone.0071189. Print 2013.
7
High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma.血管内皮生长因子的高表达与导管腺癌患者的肝转移及预后不良相关。
Cancer. 2000 May 15;88(10):2239-45. doi: 10.1002/(sici)1097-0142(20000515)88:10<2239::aid-cncr6>3.0.co;2-v.
8
Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.表达内脂素的微血管密度作为人类胃癌生存的预后因素。
World J Gastroenterol. 2016 Jun 21;22(23):5422-9. doi: 10.3748/wjg.v22.i23.5422.
9
Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer.结直肠癌中血管内皮生长因子、胸苷磷酸化酶和微血管密度的临床病理意义。
Mol Med Rep. 2016 Feb;13(2):1551-7. doi: 10.3892/mmr.2015.4687. Epub 2015 Dec 17.
10
The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.胰腺腺癌中 pSTAT3、VEGF 和 VEGF-C 的表达及临床意义。
Neoplasma. 2012;59(1):52-61. doi: 10.4149/neo_2012_007.

引用本文的文献

1
The Natural Product Parthenolide Inhibits Both Angiogenesis and Invasiveness and Improves Gemcitabine Resistance by Suppressing Nuclear Factor κB Activation in Pancreatic Cancer Cell Lines.天然产物小白菊内酯通过抑制胰腺癌细胞系中的核因子κB激活来抑制血管生成和侵袭,并改善吉西他滨耐药性。
Nutrients. 2024 Feb 29;16(5):705. doi: 10.3390/nu16050705.
2
The Role of Stroma in Cancer Metabolism.基质在癌症代谢中的作用。
Cold Spring Harb Perspect Med. 2024 May 2;14(5):a041540. doi: 10.1101/cshperspect.a041540.
3
Girdin regulates both migration and angiogenesis in pancreatic cancer cell lines.

本文引用的文献

1
What's new in therapy of pancreatic cancer?胰腺癌治疗的新进展?
Dig Dis. 2010;28(4-5):679-83. doi: 10.1159/000320096. Epub 2010 Nov 18.
2
Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium.吉西他滨联合索拉非尼治疗晚期胰腺癌患者:芝加哥大学二期联盟的一项二期临床试验。
Invest New Drugs. 2012 Feb;30(1):382-6. doi: 10.1007/s10637-010-9526-z. Epub 2010 Aug 28.
3
Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection.
Girdin 调节胰腺癌细胞系的迁移和血管生成。
Oncol Rep. 2023 Sep;50(3). doi: 10.3892/or.2023.8606. Epub 2023 Jul 28.
4
Upregulation of integrin‑linked kinase enhances tumor progression in gemcitabine‑resistant pancreatic cancer.整合素连接激酶的上调增强了吉西他滨耐药胰腺癌的肿瘤进展。
Oncol Rep. 2023 Sep;50(3). doi: 10.3892/or.2023.8601. Epub 2023 Jul 21.
5
Preoperative Multiparametric Quantitative Magnetic Resonance Imaging Correlates with Prognosis and Recurrence Patterns in Pancreatic Ductal Adenocarcinoma.术前多参数定量磁共振成像与胰腺导管腺癌的预后及复发模式相关
Cancers (Basel). 2022 Aug 31;14(17):4243. doi: 10.3390/cancers14174243.
6
10Z‑Hymenialdisine inhibits angiogenesis by suppressing NF‑κB activation in pancreatic cancer cell lines.10Z-海鞘素通过抑制 NF-κB 激活抑制胰腺癌系血管生成。
Oncol Rep. 2022 Mar;47(3). doi: 10.3892/or.2022.8259. Epub 2022 Jan 11.
7
Escin inhibits angiogenesis by suppressing interleukin‑8 and vascular endothelial growth factor production by blocking nuclear factor‑κB activation in pancreatic cancer cell lines.七叶皂苷通过抑制核因子-κB 的激活来抑制白细胞介素-8 和血管内皮生长因子的产生,从而抑制胰腺癌细胞系的血管生成。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8006. Epub 2021 Mar 24.
8
Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth.应用体素内不相干运动 MRI 和 CT 灌注评估胰腺癌组织灌注作为潜在的影像学生物标志物:与组织学微血管密度的相关性作为金标准。
Cancer Imaging. 2021 Jan 19;21(1):13. doi: 10.1186/s40644-021-00382-x.
9
The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma.LOXL2 与 GATA6 的相互作用诱导胆管癌中 VEGFA 的表达和血管生成。
Int J Oncol. 2019 Sep;55(3):657-670. doi: 10.3892/ijo.2019.4837. Epub 2019 Jul 15.
10
Expression of the PTEN/FOXO3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression.PTEN/FOXO3a/PLZF 信号通路在胰腺癌中的表达及其在肿瘤发生和进展中的意义。
Invest New Drugs. 2020 Apr;38(2):321-328. doi: 10.1007/s10637-019-00791-7. Epub 2019 May 14.
慢性胰腺炎相关胰腺癌:病因、发病概率及早期检测。
Best Pract Res Clin Gastroenterol. 2010 Jun;24(3):349-58. doi: 10.1016/j.bpg.2010.02.007.
4
The natural history of resected pancreatic cancer without adjuvant chemotherapy.未接受辅助化疗的切除性胰腺癌的自然病史。
Am Surg. 2010 May;76(5):480-5.
5
A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators.单中心可切除胰腺腺癌辅助治疗结果回顾:结果和预后指标。
J Gastrointest Surg. 2010 Jul;14(7):1159-69. doi: 10.1007/s11605-010-1213-z. Epub 2010 May 6.
6
Pancreatic cancer.胰腺癌
N Engl J Med. 2010 Apr 29;362(17):1605-17. doi: 10.1056/NEJMra0901557.
7
Analysis of 5-year survivors after a macroscopic curative pancreatectomy for invasive ductal adenocarcinoma.分析宏观根治性胰腺切除术治疗浸润性导管腺癌 5 年生存者。
World J Surg. 2010 Aug;34(8):1908-15. doi: 10.1007/s00268-010-0570-9.
8
The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells.RON 酪氨酸激酶受体调节胰腺癌细胞中血管内皮生长因子的产生。
Pancreas. 2010 Apr;39(3):301-7. doi: 10.1097/mpa.0b013e3181bb9f73.
9
Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling.基于全基因组表达谱分析的胰腺导管腺癌淋巴结转移相关的分子标志物。
Cancer Sci. 2010 Jan;101(1):259-66. doi: 10.1111/j.1349-7006.2009.01359.x. Epub 2009 Sep 10.
10
Advances in the treatment of pancreatic cancer: limitations of surgery and evaluation of new therapeutic strategies.胰腺癌治疗进展:手术局限性与新治疗策略评估
Surg Today. 2009;39(6):466-75. doi: 10.1007/s00595-008-3904-6. Epub 2009 May 27.